We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 247 results
  1. CD33 and CD33-Related Siglecs in Pathogen Recognition and Endocytosis of DC in the Innate Immune System

    CD33 is a myeloid differentiation marker antigen with immune functions associated with anti-inflammatory signaling, cell adhesion, and endocytosis....
    Chapter 2022
  2. Sialic Acid-Binding Ig-Like Lectins (Siglecs)

    During the mid-1980s, in vitro rosette formation between macrophages and sheep erythrocytes was reported; however, sialidase treatment on...
    Chapter 2022
  3. Regulation of prognosis-related Siglecs in the glioma microenvironment

    Purpose

    The anti-inflammatory environment of glioma reduces the efficacy of immunotherapies. Therefore, it is vital to transform the immunosuppressive...

    Rui Mao, Liting Zhou, ... Dong Zhou in Journal of Cancer Research and Clinical Oncology
    Article 01 September 2021
  4. CD33 as a leukocyte-associated marker expressed on human spermatozoa

    Objective

    Sialic acid-binding immunoglobulin-type lectins (Siglecs) are commonly present on immune cells and often mediate cell-to-cell interactions...

    Nasrin Sereshki, Mitra Rafiee, ... David Wilkinson in BMC Research Notes
    Article Open access 20 April 2023
  5. The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans

    Carbohydrates — namely glycans — decorate every cell in the human body and most secreted proteins. Advances in genomics, glycoproteomics and tools...

    Benjamin A. H. Smith, Carolyn R. Bertozzi in Nature Reviews Drug Discovery
    Article 18 January 2021
  6. Impact of the Siglec-Sialoglycan Axis on the Cancer Immune Response

    Sialic acid-binding immunoglobulin-like lectins (Siglecs) have heavily mediated the tumour landscape and shown significant deregulation in many...
    Mohammed Saqif Ahmad, Sara Seriah, Shoib Sarwar Siddiqui in
    Chapter 2024
  7. Siglecs at the Host–Pathogen Interface

    Siglecs are sialic acid (Sia) recognizing immunoglobulin-like receptors expressed on the surface of all the major leukocyte lineages in mammals....
    Yung-Chi Chang, Victor Nizet in Lectin in Host Defense Against Microbial Infections
    Chapter 2020
  8. Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma

    Sarcomas (SARC) are a highly heterogeneous cancer type that is prone to recurrence and metastasis. Numerous studies have confirmed that Siglecs are...

    Lili Qi, Kuiying Jiang, ... Ling Wang in Scientific Reports
    Article Open access 05 January 2024
  9. Gangliosides as Siglec ligands

    The structure of a sialoglycan can be translated into to a biological response when it binds to a specific endogenous lectin. Among endogenous sialic...

    Ronald L. Schnaar in Glycoconjugate Journal
    Article 26 January 2023
  10. Siglecs that Associate with DAP12

    Siglecs are a family of transmembrane receptor-like glycan-recognition proteins expressed primarily on leukocytes. Majority of Siglecs have an...
    Chapter 2020
  11. Substantial Basis for Glyco-Assembly: Siglec7 and Synthetic Sialylpolymers

    Sialic acid is one of the tags that are recognized as “self,” when immune cells survey “non-self” items using the sialic acid-recognizing lectins,...
    Sayo Morishita, Masaya Hane, ... Chihiro Sato in Glycosignals in Cancer
    Chapter 2023
  12. The intriguing roles of Siglec family members in the tumor microenvironment

    Sialic acid-binding receptors are expressed on the surfaces of a variety of immune cells and have complex and diverse immunoregulatory functions in...

    Kui-Ying Jiang, Li-Li Qi, ... Ling Wang in Biomarker Research
    Article Open access 13 April 2022
  13. Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells

    Mast cells (MC) are key drivers of allergic and inflammatory diseases. Sialic acid-binding immunoglobulin-like lectin (Siglec)-6 is an...

    Julia Schanin, Wouter Korver, ... Bradford A. Youngblood in Communications Biology
    Article Open access 11 November 2022
  14. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients

    Background

    Acute myeloid leukemia (AML) is a group of highly heterogenous and aggressive blood cancer. Despite recent progress in its diagnosis and...

    Huiping Shi, Liang Gao, ... Min Jiang in BMC Bioinformatics
    Article Open access 19 July 2022
  15. Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses

    The mammalian immune system evolved to tightly regulate the elimination of pathogenic microbes and neoplastic transformed cells while tolerating our...

    Heinz Läubli, Ajit Varki in Cellular and Molecular Life Sciences
    Article 04 September 2019
  16. Microglial TYROBP/DAP12 in Alzheimer’s disease: Transduction of physiological and pathological signals across TREM2

    TYROBP (also known as DAP12 or KARAP) is a transmembrane adaptor protein initially described as a receptor-activating subunit component of natural...

    Jean-Vianney Haure-Mirande, Mickael Audrain, ... Sam Gandy in Molecular Neurodegeneration
    Article Open access 24 August 2022
  17. Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells

    To date, IgG in the tumor microenvironment (TME) has been considered a product of B cells and serves as an antitumor antibody. However, in this...

    Zihan Wang, Zihan Geng, ... Xiaoyan Qiu in Cellular & Molecular Immunology
    Article 21 November 2019
  18. Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer

    Long non-coding RNAs (lncRNAs) and Sialic acid-binding immunoglobulin-type lectin (SIGLEC) family members play an important role in proliferation,...

    Xin Jin, Ying Chen, Qing Hu in Scientific Reports
    Article Open access 31 March 2024
  19. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions

    The small, heavily glycosylated protein CD24 is primarily expressed by many immune cells and is highly expressed mostly in cancer cells. As one of...

    Xingchen Li, Wenzhi Tian, ... Jifeng Yu in Cancer Immunology, Immunotherapy
    Article Open access 27 January 2024
  20. Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

    Background

    Aberrant sialoglycans on the surface of tumor cells shield potential tumor antigen epitopes, escape recognition, and suppress activation of...

    Jianmei Huang, Meiying Li, ... Guonan Zhang in Journal of Translational Medicine
    Article Open access 31 October 2022
Did you find what you were looking for? Share feedback.